Oak Ridge Investments’s Charles River Laboratories CRL Stock Holding History

Oak Ridge Investments’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,090	Closed	-$805K	–	152
2022 Q3	$805K	Hold	4,090	–	–	0.12%	132
2022 Q2	$875K	Hold	4,090	–	–	0.13%	126
2022 Q1	$1.16M	Sell	4,090 -10	-0.2%	-$3.08K	0.13%	124
2021 Q4	$1.54M	Sell	4,100 -240	-6%	-$93.2K	0.13%	119
2021 Q3	$1.79M	Sell	4,340 -1,128	-21%	-$468K	0.16%	118
2021 Q2	$2.02M	Sell	5,468 -43	-0.8%	-$14.4K	0.18%	115
2021 Q1	$1.6M	Sell	5,511 -314	-5%	-$87.3K	0.15%	115
2020 Q4	$1.46M	Sell	5,825 -151	-3%	-$36K	0.13%	125
2020 Q3	$1.35M	Buy	5,976 +28	+0.5%	+$5.81K	0.11%	123
2020 Q2	$1.04M	Sell	5,948 -56	-0.9%	-$8.94K	0.09%	125
2020 Q1	$758K	Buy	6,004 +1,708	+40%	+$256K	0.08%	130
2019 Q4	$656K	Buy	+4,296	New	+$595K	0.05%	155

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Oak Ridge Investments's CRL Position: Q4 2022 in Review

Oak Ridge Investments sold out of Charles River Laboratories (CRL) in Q4 2022, closing a stake of 4,090 shares — an estimated $805K sold.

Oak Ridge Investments first reported a position in CRL in Q4 2019 and held it in 12 quarters. The position peaked at $2.02M in Q2 2021. 627 funds tracked by Wall St. Rank hold CRL as of Q4 2022.

Oak Ridge Investments reported no remaining Charles River Laboratories position as of Q4 2022 after selling out during the quarter.
Oak Ridge Investments sold 4,090 Charles River Laboratories shares in Q4 2022, an estimated $805K.
Oak Ridge Investments first reported a position in Charles River Laboratories in Q4 2019 and held it in 12 quarters.
Oak Ridge Investments's Charles River Laboratories position peaked at $2.02M in Q2 2021.
627 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2022.

Based on Oak Ridge Investments's 13F filing for Q4 2022, filed 24 Jan 2023.